《大行報告》麥格理上調新秀麗(01910.HK)目標價至26元 評級「跑贏大市」
麥格理髮表報告指,新秀麗(01910.HK)第三季業績穩健,經營溢利扭虧賺5,070萬美元,是自新冠疫情以來首次實現盈利,以固定匯率計銷售額較2019年同期下降37.6%,但仍好過該行預期的下跌40%。
公司預料,明年收入跌幅有望收窄至15%至20%,經調整EBITDA利潤率達14%至16%。麥格理相信上述目標可以實現,重申其「跑贏大市」評級。
該行維持對新秀麗2022年盈利預測,而將2023年盈利預測上調4%,以反映收入復甦高於預期,目標價相應由25元提高到26元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.